Orca Bio
Tiffany Scharadin is a seasoned GMP and Translational Research Scientist at Orca Bio since June 2019, with prior experience as a Scientist contracted with Accelerated Medical Diagnostics. Notably, Tiffany has a robust background in cancer research from a postdoctoral position at UC Davis Medical Center, where significant contributions included developing biomarker assays and identifying drug resistance genes. Educational credentials include a PhD in Molecular Medicine from the University of Maryland Baltimore and a BS in Zoology and Chemistry from the State University of New York at Oswego. Tiffany's extensive research experience is complemented by a commitment to science communication and engagement, demonstrated during an internship at the Maryland Science Center.
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.